Additionally, significant differences were observed between acral and non-acral melanoma in the anti-PD1 Abs cohort (HR, 0.52; 95% CI, 0.30–0.89; p = 0.016, Figure 1b). This evidence concerns the gene PDCD1 and melanoma.